A local biotech company is eyeing major growth after acquiring platform technology from global pharmaceutical giant GlaxoSmithKline Inc.
….The UW-Madison spinoff, which was formed six years ago, now expects to become profitable within two years, although one giant deal could make it instantly profitable, according to GenTel CEO Alex Vodenlich.